<DOC>
	<DOCNO>NCT00392912</DOCNO>
	<brief_summary>Treatment testosterone improve performance test spatial ability men low testosterone level Alzheimer 's disease . Improved performance test may mean improve ability get around one 's environment without get lose injured . This could positive impact patient care . We investigate area brain involved improvement spatial ability . This do use PET scan , create 3-dimensional image brain allow u see brain function .</brief_summary>
	<brief_title>Effect Testosterone Therapy Men With Alzheimer 's Disease Low Testosterone</brief_title>
	<detailed_description>Volunteers treat prescription testosterone gel apply shoulder body area day . This treatment continue 6 month . Subjects undergo PET scan beginning study approximately 2 month treatment . Subjects undergo cognitive test throughout study .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Alzheimer 's disease diagnosis , base Diagnostic Statistical Manual Mental Disorders ( 5th ed . ; DSMV ) Total testosterone &lt; 300 ng/dL and/or calculate free testosterone &lt; 50 pg/ml Sufficient English perform cognitive test Stable concomitant medication 1 month prior start study history prostate cancer history breast cancer gonadal endocrine disorder current major psychiatric illness ( exclude depression ) significant uncontrolled systemic illness recent myocardial infarction ( within 6 month ) renal hepatic disease , sleep apnea history alcoholism substance abuse within past year history head injury loss consciousness great 1 hour testosterone androgen treatment within past 3 month history take drug might interfere result study ( ie , spironolactone , cimetidine , antiandrogens , estrogen , p450 enzyme inducer , barbiturate ) symptomatic BPH : prostatic symptom , prostatic mass induration rectal examination prostate specific antigen ( PSA ) &gt; 4.0 mg/mL hemoglobin &gt; 17 mg/dL generalize skin disease could affect absorption testosterone gel ( ie , psoriasis ) . potentially agitated uncooperative procedure</criteria>
	<gender>Male</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>testosterone</keyword>
	<keyword>hypogonadal</keyword>
	<keyword>cerebral glucose metabolism</keyword>
	<keyword>PET scan</keyword>
	<keyword>Alzheimer 's disease</keyword>
</DOC>